Lanean...
Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence
In optimizing anticoagulation therapy, it is essential to balance treatment efficacy with the major adverse effect of anticoagulant treatment, bleeding risk. This narrative review examines the efficacy and safety of the non-vitamin K antagonist oral anticoagulants (NOACs) dabigatran, rivaroxaban, ap...
Gorde:
| Argitaratua izan da: | Ther Adv Cardiovasc Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6266250/ https://ncbi.nlm.nih.gov/pubmed/30270775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944718801554 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|